Home
Blog
Features
Sign Up
Try the Demo today!
Home
Market
Reports
Search
Alerts
Ticker
Company Name
Insider Name
Insider Trading Guide
About
Contact Us
Login
Gold Mitchell
Insider Overview
Current Sentiment
Insider Transactions
Email this page »
View:
Company
Dendreon Corp.
Nivalis Therapeutics, Inc.
Dendreon Corp.
Director
Avg. Two Year Performance
(35%)
Avg. Purchase Return
(16%)
Compound
38%
Avg. Sale Return
18%
Compound
Holdings:
457.26K
shares
Last Three Months: 23-Aug-24 -- 22-Nov-24
0
Net Amount
Buy:
0
--
Sell:
0
--
Sentiment
Company Sentiment
Biotechnology
Drugs
Two Year Chart
23-Nov-22 -- 22-Nov-24
Price ($)
Sentiment
Company Sentiment
Most Recent Insider Transactions
